To determine whether L-Bcl-2 antisense oligonucleotide treatment could also sensitize AML cells to chemotherapeutic agents, Konopleva and colleagues.28also examined AML cell viability on the combined treatment of the L-Bcl-2 antisense oligonucleotide with cytosine-arabinoside (ara-C), the drug used ...